Skip to main content
. 2011 Jan 27;16(2):291–299. doi: 10.1111/j.1440-1843.2010.01897.x

Table 6.

Sputum cell differentials at Visit 2 for acute asthma with viral persistence and viral clearance

Viral persistence Viral clearance P‐value
Acute asthma, virus positive Visit 1, positive Visit 2 Acute asthma, virus positive Visit 1, negative Visit 2
n 15 14
Total cell count (×106/mL) 4.77 (1.89, 5.76) 2.88 (1.17, 4.68) 0.327
Neutrophils (%) 34.8 (10.3, 53.5) 14.3 (9.0, 42.3) 0.316
Neutrophils (×104/mL) 130.4 (82.0, 200.2) 111.7 (7.6, 165.9) 0.462
Eosinophils (%) 1.9 (1, 4.4) 5.3 (0.3, 15.6) 0.303
Eosinophils (×104/mL) 5.9 (0, 7.3) 3.3 (0, 40.8) 0.967
Macrophages (%) 57.0 (43.3, 68.3) 64.6 (42.3, 83.9) 0.601
Macrophages (×104/mL) 255.5 (81.7, 431.9) 100.3 (78.2, 269.9) 0.414
Lymphocytes (%) 0.8 (0, 1.9) 0.5 (0, 3.5) 0.930
Lymphocytes (×104/mL) 3.0 (0, 7.2) 1.2 (0, 3.5) 0.481
Columnar epithelial cells (%) 0.5 (0.3, 2.5) 0.6 (0, 1.2) 0.343
Columnar epithelial cells (×104/mL) 4.0 (1.7, 10.9) 3.1 (0, 3.4) 0.151
Squamous contamination (%) 8.3 (3.2, 25.0) 3.3 (0.7, 12.0) 0.106

Results are median (IQR), Wilcoxon rank sum test.